Skip to content

A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting

A Study of the Image Quality in Coronary or Craniocervical CT Angiography With Different Iodine Delivery Rates Using Low Tube Voltage (80 or 100 kV) Imaging in MDCT

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02840903
Acronym
RIGHT
Enrollment
1214
Registered
2016-07-21
Start date
2016-07-26
Completion date
2017-10-11
Last updated
2018-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angiography, Multidetector Computed Tomography

Keywords

CTA, Computed Tomographic Angiography

Brief summary

The objective of this study is to evaluate the image quality for different iodine delivery rates at different low voltage scanning protocols (80 or 100 kV ) under the modern advanced Multi-Detector Computed Tomography (MDCT) considering the body weight of patients.

Detailed description

The purpose of this study is to evaluate the image quality of different acquisition protocols in patients weighing less than 90 kg using low voltage 80 or 100 kV with a lower Iodine Delivery Rate based on the body weight of the patient, who will undertake coronary or craniocervical CTA (Computed Tomography Angiography) in routine procedures.

Interventions

8 settings for CT Angiography as described in group description.

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients for whom the decision to initiate CTA will be made as per investigator's routine practice. * Adult patients (age ≥18 years) with a weight ≤ 90 kg. * Written Informed Consent.

Exclusion criteria

* A history of hypersensitivity to iodinated contrast agents. * Known or suspected hyperthyroidism or pheochromocytoma. * Atrial fibrillation or any other cardiac arrhythmia that would preclude reliable ECG gating; have severe congestive heart failure (New York Heart Classification IV). * Pregnant or lactating women. * Patients participating in another clinical study. * Patients who underwent PCI (percutaneous coronary intervention) or CABG (coronary artery bypass grafting) before the index CTA.

Design outcomes

Primary

MeasureTime frameDescription
Contrast opacification of the target vascular segments, measured in Hounsfield Units (HU)Up to 1 weekDefined as the CT value which can be measured on the CTA images.

Secondary

MeasureTime frameDescription
Value of SNR (signal-noise ratio) of the vascular segmentsUp to 1 weekCalculated by the formula: SNR = Averaged vascular segmental CT value / image noise
Score of visual assessment of the CTA image qualityUp to 1 weekSubjective visual assessment using a 4-point scale: 1. Non-diagnostic 2. Adequate 3. Good 4. Excellent
Score of diagnostic confidence of the CTA imagesUp to 1 weekSubjective assessment of diagnostic confidence in the delineation of pathologic findings using a 4-point scale: 1. Insufficient 2. Adequate 3. Good 4. Excellent
Injected dosage (ml) of the contrast media (CM)Up to 24 hoursCan be read from the screen of the CT injector.
Injection rate (ml/s) of the contrast mediaUp to 24 hoursCan be read from the screen of the CT injector.
Value of the Idoine delivery rate (IDR) (unit: mg I/s)Up to 1 weekCalculated by the formula: IDR (mg I/s) = CM concentration (mg I/ml) \* CM injection rate (ml/s)
Value of CNR (contrast-noise ratio) of the vascular segmentsUp to 1 weekCalculated by the formula: CNR = \[Averaged vascular segmental CT value - brain parenchyma (for carniocervical CTA) / perivascular tissues (for Coronary CTA (CCTA)) CT value\] / image noise
Value of the dose length product (DLP) (unit: mGy*cm)Up to 1 weekA parameter of the radiation dose which can be automatically generated and recorded by the CT machine.
Value of the effective dose (organ dose) (unit: mSv)Up to 1 weekThe effective radiation dose which can be estimated by DLP multiplied by a specific conversion coefficient.
Heart rate of the patients who underwent CCTA before and after the CM injectionUp to 24 hoursIt can be read from the screen of the ECG monitor of the CT machine
Presence of injection pain or discomfort of the patients (Yes/No)Up to 24 hoursAssessed by investigators by asking patients if they have injection pain or discomfort.
Number of patients with adverse events / adverse drug reactionsUp to 1 hour
Severity of injection pain or discomfort of the patientsUp to 24 hoursAssessed by investigators by asking the patients of the severity (mild, moderate, severe) if present.
Value of the volume CT dose index (CTDIvol) (unit: mGy)Up to 1 weekA parameter of the radiation dose which can be automatically generated and recorded by the CT machine.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026